How Long Can We Leave Patients With Pulmonary Arterial Hypertension on Oral Drug Monotreatment?

被引：0
|
作者：
Ogawa, Aiko [1 ]
Matsubara, Hiromi [1 ]
机构：
[1] Natl Hosp Org, Dept Clin Sci, Okayama Med Ctr, Kita Ku, Okayama 7011192, Japan
来源：
CIRCULATION JOURNAL | 2012年 / 76卷 / 05期
关键词：
SILDENAFIL CITRATE; PROGNOSTIC-FACTORS; SURVIVAL; THERAPY;
D O I：
10.1253/circj.CJ-12-0341
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1089 / 1090
页数：2
相关论文
共 50 条
  • [1] Impact of First-Line Sildenafil Monotreatment for Pulmonary Arterial Hypertension
    Yanagisawa, Ryoji
    Kataoka, Masaharu
    Taguchi, Hiroki
    Kawakami, Takashi
    Tamura, Yuichi
    Fukuda, Keiichi
    Yoshino, Hideaki
    Satoh, Toni
    CIRCULATION JOURNAL, 2012, 76 (05) : 1245 - 1252
  • [2] Idiopathic Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension: Can We Be Certain?
    Berger, Gidon
    Azzam, Zaher S.
    Hardak, Emilia
    Tavor, Yonit
    Yigla, Mordechai
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (02): : 106 - 110
  • [3] Pregnant with pulmonary arterial hypertension - Can we handle the pressure?
    Low, Ting Ting
    Granton, John
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 328 : 180 - 181
  • [4] What we need to know about drug interactions in patients with pulmonary arterial hypertension
    Wustmann, K.
    Schmidheiny, P.
    Schwerzmann, M.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2012, 34 (02) : 119 - 122
  • [5] Surgery for mitral stenosis in patients with pulmonary hypertension: How far can we go?
    Coutinho, Goncalo F.
    Antunes, Manuel J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 152 (02): : 302 - 303
  • [6] Pulmonary hypertension trials: how can we do better?
    Hill, Nicholas S.
    Roberts, Kari
    Preston, Ioana
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (05) : 551 - 558
  • [7] The Early Diagnosis of Pulmonary Arterial Hypertension Can We Do Better?
    Palevsky, Harold I.
    CHEST, 2011, 140 (01) : 4 - 6
  • [8] Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factors
    Charalampopoulos, Athanasios
    Howard, Luke S.
    Tzoulaki, Ioanna
    Gin-Sing, Wendy
    Grapsa, Julia
    Wilkins, Martin R.
    Davies, Rachel J.
    Nihoyannopoulos, Petros
    Connolly, Susan B.
    Gibbs, J. Simon R.
    PULMONARY CIRCULATION, 2014, 4 (04) : 669 - 678
  • [9] How should we best determine the need for inflight oxygen in patients with pulmonary arterial hypertension?
    Burns, Roslyn M.
    Johnson, Martin K.
    Church, Alistair Colin
    THORAX, 2013, 68 (07) : 680 - 680
  • [10] How Can We Improve the Management of Patients with Hypertension?
    Alpert, Joseph S.
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (01): : 1 - 2
12345